$98.60 +1.51 (%) Ligand Pharmaceuticals Inc - NASDAQ

Jul. 2, 2015 | 04:00 PM

Partner Headlines

  1. LIGAND PHARMACEUTICALS

    IBD | Jun. 2, 2015 | 18:36PM EST
  2. Regeneron, Lannett Among The 4 Top-Rated Drug Stocks

    IBD | May. 28, 2015 | 08:02AM EST
  3. Actavis, Ligand Top Q1 Views

    IBD | May. 11, 2015 | 18:46PM EST
  4. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 18:36PM EST
  5. Q1 Earnings Drive Industry Group Winners And Losers

    IBD | May. 8, 2015 | 18:59PM EST
  6. CRT Capital Initiates Ligand Pharmaceuticals With Buy

    Benzinga | Mar. 3, 2015 | 09:24AM EST
  7. Benzinga's Top Initiations

    Benzinga | Mar. 3, 2015 | 09:07AM EST
  8. Morning Market Losers

    Benzinga | Feb. 9, 2015 | 10:00AM EST
  9. UPDATE: Ligand Pharmaceuticals Posts In-Line Q4 Earnings, Issues Weak Outlook

    Benzinga | Feb. 9, 2015 | 09:17AM EST
  10. Earnings Scheduled For February 9, 2015

    Benzinga | Feb. 9, 2015 | 04:58AM EST
  11. UPDATE: Deutsche Bank Initiates Coverage On Ligand Pharmaceuticals On Growing Royalty Play On Biopharma

    Benzinga | Dec. 2, 2014 | 08:05AM EST
  12. Lemelson Capital Management CIO Discusses Ligand Pharmaceuticals Prior To Company Issuing Weak Guidance

    Benzinga | Nov. 18, 2014 | 15:56PM EST
  13. Why Lemelson Capital Is Short On Ligand Pharmaceuticals

    Benzinga | Oct. 17, 2014 | 15:52PM EST
  14. Dow Surges Over 200 Points After FOMC Minutes; Blackhawk Shares Jump On Strong Results

    Benzinga | Oct. 8, 2014 | 15:40PM EST
  15. Interface Drops On Q3 Warning; Symantec Shares Rise

    Benzinga | Oct. 8, 2014 | 14:03PM EST
  16. Ligand Pharmaceuticals Inc. Shares Gain On Q3 Pre-Announcement

    Benzinga | Oct. 8, 2014 | 11:35AM EST
  17. Mid-Morning Market Update: Markets Mostly Flat; Costco Posts Upbeat Earnings

    Benzinga | Oct. 8, 2014 | 10:00AM EST
  18. Morning Market Movers

    Benzinga | Oct. 8, 2014 | 09:36AM EST
  19. Stocks To Watch For August 12, 2014

    Benzinga | Aug. 12, 2014 | 04:04AM EST
  20. Exclusive: Emmanuel Lemelson Talks Ligand Pharmaceuticals

    Benzinga | Aug. 7, 2014 | 13:57PM EST
  21. Ligand Pharmaceuticals Reports Earnings; Lemelson Capital Adds To Short Position

    Benzinga | Aug. 4, 2014 | 15:45PM EST
  22. Earnings Scheduled For August 4, 2014

    Benzinga | Aug. 4, 2014 | 05:14AM EST
  23. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On Downbeat Results

    Benzinga | Jul. 16, 2014 | 15:57PM EST
  24. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga | Jul. 16, 2014 | 13:36PM EST
  25. Benzinga's Volume Movers

    Benzinga | Jun. 24, 2014 | 10:41AM EST
  26. Ligand to Present Positive Data from Phase 1 Study of Effect of SERN Lasofoxifene

    Benzinga | Jun. 23, 2014 | 08:03AM EST
  27. Shares Of Ligand Follow Parabolic Curve Amid Responses Surrounding Promacta's Phase III Trial

    Benzinga | Jun. 17, 2014 | 12:26PM EST
  28. Ligand Pharmaceuticals - Severe competitive threat to key royalty program and "going ...

    GuruFocus | Jun. 16, 2014 | 18:37PM EST
  29. Indexes End With Small Gains; Tesla Drives Higher

    IBD | Jun. 16, 2014 | 16:25PM EST
  30. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals for Dyslipidemia-related Diseases

    Benzinga | May. 14, 2014 | 08:35AM EST
  31. UPDATE: Ligand Pharma Announces Milestone from Sage Therapeutics for SAGE-547

    Benzinga | May. 12, 2014 | 08:05AM EST
  32. Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

    Benzinga | Apr. 23, 2014 | 07:12AM EST
  33. UPDATE: MLV & Co Reiterates on Ligand Pharmaceuticals Following Strong 4Q Report

    Benzinga | Feb. 13, 2014 | 08:08AM EST
  34. Stocks End Near Session Highs; Ligand, Regeneron Jump

    IBD | Feb. 11, 2014 | 16:24PM EST
  35. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD | Jan. 13, 2014 | 17:44PM EST
  36. UPDATE: Cantor Fitzgerald Raises PT on Ligand Pharmaceuticals as Key Partnered Program Advances

    Benzinga | Dec. 10, 2013 | 12:34PM EST
  37. Ligand Pharmaceuticals Sees Q4 EPS $0.31-$0.32 vs $0.22-$0.24; Q4 Revenue $14.0M-$14.5M vs $11.0M-$12.0M

    Benzinga | Dec. 4, 2013 | 05:57AM EST
  38. A Few Stocks Form Bases, But Have Flaws

    IBD | Nov. 20, 2013 | 18:30PM EST
  39. Ligand Pharmaceuticals On Pace For Annual Profit

    IBD | Nov. 5, 2013 | 17:25PM EST
  40. Ligand, NIC: Thinly Traded Stocks That Hold Promise

    IBD | Oct. 24, 2013 | 17:17PM EST
  41. Ligand Partner GSK Receives Marketing Authorization from EC for Additional Revolade Indication as Treatment for Chronic Hepatitis C-Associated Thrombocytopenia

    Benzinga | Sep. 24, 2013 | 07:06AM EST
  42. Ligand Enters Global License Agreement with CURx Pharmaceuticals for Captisol-Enabled Topiramate Injection

    Benzinga | Aug. 14, 2013 | 08:04AM EST
  43. Ligand Receives FDA Orphan Designation for Captisol-Enabled Topiramate Injection

    Benzinga | Jul. 26, 2013 | 06:37AM EST
  44. UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers PT

    Benzinga | Jan. 4, 2013 | 01:38AM EST
  45. FDA Accepts NDA for Pfizer, Ligand's Bazedoxifene/Conjugated Estrogens

    Benzinga | Dec. 13, 2012 | 10:05AM EST
  46. Ligand Pharma Begins Pivotal Trial of Captisol-Enabled Propylene Glycol-Free Melphalan for Multiple Myeloma Patients

    Benzinga | Dec. 10, 2012 | 09:09AM EST
  47. Ligand Pharmaceuticals, Inc. (LGND) CEO John L Higgins buys 2,000 Shares

    GuruFocus | Dec. 5, 2012 | 11:06AM EST
  48. Benzinga's Volume Movers

    Benzinga | Nov. 19, 2012 | 03:46AM EST
  49. Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication

    Benzinga | Nov. 19, 2012 | 02:11AM EST
  50. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K/A)

    GuruFocus | Nov. 14, 2012 | 09:06AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!